Compass Therapeutics (CMPX) Other Gross PP&E Adjustments (2023 - 2025)
Compass Therapeutics' Other Gross PP&E Adjustments history spans 3 years, with the latest figure at -$7.4 million for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments fell 86.87% year-over-year to -$7.4 million; the TTM value through Dec 2025 reached -$7.4 million, down 86.87%, while the annual FY2025 figure was -$7.4 million, 86.87% down from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$7.4 million at Compass Therapeutics, down from -$2.7 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $6.0 million in Q2 2024 and bottomed at -$7.4 million in Q4 2025.
- The 3-year median for Other Gross PP&E Adjustments is $1.5 million (2023), against an average of $1.0 million.
- The largest annual shift saw Other Gross PP&E Adjustments increased 27.9% in 2024 before it crashed 1147.49% in 2025.
- A 3-year view of Other Gross PP&E Adjustments shows it stood at $2.7 million in 2023, then plummeted by 246.54% to -$3.9 million in 2024, then crashed by 86.87% to -$7.4 million in 2025.
- Per Business Quant, the three most recent readings for CMPX's Other Gross PP&E Adjustments are -$7.4 million (Q4 2025), -$2.7 million (Q3 2025), and -$3.1 million (Q2 2025).